Targeting mutant estrogen receptors.

Elife

Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, United States.

Published: January 2019

A drug used in hormone replacement therapy can target estrogen receptors that have become resistant to breast cancer treatments.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335051PMC
http://dx.doi.org/10.7554/eLife.44181DOI Listing

Publication Analysis

Top Keywords

estrogen receptors
8
targeting mutant
4
mutant estrogen
4
receptors drug
4
drug hormone
4
hormone replacement
4
replacement therapy
4
therapy target
4
target estrogen
4
receptors resistant
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!